Walter Bee

About Walter Bee

Proven leader with 30+ years of global experience in nonclinical and preclinical drug development, strategic CRO management, regulatory consulting, and biomarker development. Deep expertise spanning small and large molecules, biologics, medical devices, and industrial chemicals. Former Senior Vice President, Vice President, and Director at top biotech companies and global CROs. Known for effective leadership in outsourced research models, operational excellence, and scientific and regulatory strategy across diverse therapeutic areas. Board-ready, with a strong record in governance, quality oversight, and program execution.

Experience

1. Senior Vice President, Biomarker and Preclinical Development

   Transposon Therapeutics, Inc

   Jul 2020 — Present · San Diego, CA, US

   Strategic leadership for biomarker and preclinical programs supporting neurodegenerative disease therapeutics.Integrated preclinical toxicology, pharmacology, and biomarker strategy aligned with clinical objectives.Member of the Quality Leadership Team; active contributor to regulatory document preparation.

Education

• University of Münster

  Dr. rer. nat., Zoology

  1979 — 1989

• Märkisches Gymnasium, Hamm

  Abitur, Biology, History

  1967 — 1976

Skills

• Technology Transfer
• Biomarkers
• Regulatory Submissions
• In Vivo
• Subcutaneous
• Life Sciences
• Cell
• Clinical Study Design
• 21 Cfr Part 11
• Chemistry
• Drug Discovery
• Pharmacology
• Regulatory Affairs
• Lifesciences
• Biologics
• Validation
• Formulation
• R&D
• Translational Medicine
• Pharmacokinetics
• Oncology
• Protocol
• Vaccines
• Medical Writing
• Infectious Diseases
• Good Laboratory Practice (Glp)
• Biotechnology
• Subcutaneous Dosing
• Ocular Toxicology
• Reproductive
• Clinical Research
• Clinical Pharmacology
• Nda
• Ind
• Regulatory Toxicology
• Reproductive Toxicology
• CRO
• Toxicology
• Pharmaceutical Industry
• Sop